🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Non c'è nessun posto dove nasconderti quando a perseguitati è la tua mente.

Great summary of genes on prostate cancer panels and current implications for #prostatecancer risk & treatment, as well as for hereditary cancer risk in families -Veda Giri at BRCA Research & Cure Alliance (CureBRCA) meeting

Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study by Chiara Casadei et al Read the full article here: eu-openscience.europeanurology.com/article/S2666-… #UroSoMe #Medtwitter #ProstateCancer #PCa

Practical approach to #GeneticTesting and treatment selection in #ProstateCancer. Presentation by David VanderWeele MD PhD Lurie Cancer Center. #ASCO24 written coverage by Julian Chavarriaga University of Toronto > bit.ly/4aH3yOZ Northwestern Feinberg School of Medicine

Independent blinded validation of an AI-based digital histology classifier (PATHOMIQ_PRAD score) for BCR and mets risk prediction #ASCO24 Magdalena Fay, MD MS UroToday.com Cleveland Clinic Urology ⚡️n=263 RP (mF/U 50 mo) -> 65 BCR -> 14 distant mets ⚡️PATHOMIQ_PRAD score ⬆️ vs ⬇️: assoc with BCRFS

Probably an outdated discussion, but our randomized trial Open versus RARP was finally published. A Herculean effort that started 10 years ago

📢 Nuova possibilità di cura per pazienti affetti da tumore vescicale muscolo infiltrante eleggibili a chirurgia. Prima evidenza di come l'immunoterapia ⬆️ la sopravvivenza insieme alla chemioterapia! ✅️ astrazeneca.com/media-centre/p… associazionepalinuro

Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent PCs Death—Results from the Norwegian Prostate Cancer Consortium by Johan Bjerner et al. Read the full article here: buff.ly/45B4T9m Ola Bratt Kirsti Aas Andrew Vickers Sigrid Carlsson

Fluorine-18 PSMA-1007 PET/CT vs Multiparametric MRI for Prostate Cancer Staging 🔵Tumor Stage: 18F-PSMA-1007 PET/CT superior (45% vs 28%) 🔵Dominant Nodule: PET/CT better (94% vs 83%) 🔵Laterality: PET/CT better (64% vs 44%) 🔵ECE: PET/CT better (75% vs 63%) 🔵SVI: Not

🎤 Dünyanın dört bir yanından uzmanlar 33. Ulusal Üroloji Kongresi'nde buluşuyor! 🌍 Bilim, bilgi ve deneyim paylaşımı için geri sayım başladı. 📅 29 Ekim - 1 Kasım 📍 Antalya 🇺🇸 🇮🇹 🇶🇦 🇺🇸 🇬🇷 🇬🇧 🇬🇧 🇫🇷 🇮🇹 🇮🇹 🇮🇹 🇵🇱 🇲🇽 🇪🇸 🇦🇹 🇷🇸 🇪🇬 🇮🇹 🇧🇦 🇽🇰 🇦🇿 🇽🇰 🇲🇰 🇬🇷 🇦🇱 🇬🇷 #UlusalÜroloji24

“Scratching” our abstract during ICS, like a DJ. #ICS2024 #MyICS

Great to meet many colleagues during Serbia Urology Meeting European School of Urology (EAU ESU) complications management session! Many Q&A from the audience during case discussion. Thanks very much for the invitation! EVANGELOS LIATSIKOS Maria Chiara Sighinolfi European Association of Urology (EAU) Bernardo Rocco, MD,FRCS (Glasgow) Theodoros Tokas

🌟New #SpecialIssue “Advances in the Management of Pelvic Tumors” edited by Dr. Giorgia Gaia and Dr. Maria Chiara Sighinolfi is #openforsubmissions! Maria Chiara Sighinolfi ASST Santi Paolo e Carlo ⏰Deadline for manuscript submissions: 1 September 2025 🔗More details: mdpi.com/journal/cancer…

A new meta-analysis published this month in Annals suggests that patients treated by female surgeons have lower mortality than those treated by male surgeons. journals.lww.com/annalsofsurger…

📢 7-8 marzo vi aspetto a #Holita, il congresso dedicato ai laser in urologia ! 18 live surgery #IPB e #calcolosi dal Policlinico di Tor Vergata. 📍Iscrizioni partnergraf.it Società Italiana di Urologia Regione Lazio Policlinico Tor Vergata Università di Roma Tor Vergata #Holita #IPB #Calcolosi #Holep

Relationship Between Undetectable PSA Nadir and Outcomes for Patients with #mHSPC in #IRONMAN, the International Registry for Men with Advanced #ProstateCancer. Undetectable PSA Nadir Predicts Better Outcomes in mHSPC 🔹 IRONMAN registry real-world data shows: ✅ 51% (6mo) &

On my way back home from #ascoGU25 Great discussion yesterday by Elizabeth Plimack MD of #CheckMate 274 / #NIAGARA in the context of perioperative + adjuvant immunotherapy in #bladdercancer OncoDaily UroToday.com

A simple summary with the most updated results from the phase 3 trials with available IO-combos in mRCC after #GU25. OncoAlert UroToday.com GU Oncology Now UroFocus Società Italiana di Urologia SIUrO

#UROFEM25 Join us in Milan, Live surgeries by top female urologists & panels challenging stereotypes. Let’s celebrate urological excellence and inspire the next gen! Silvia Secco Franco Gaboardi Maria J. Ribal bit.ly/ProgramUROFEM25 bit.ly/RegistrationUR…

Robotic-assisted cystectomy strategies: 🔬 21 expert surgeons analyzed 🤖 Demanding ileourethral approximation: 86% 🏗️ Studer/Bordeaux reconstructions popular 📉 Trendelenburg reduction: 43% #Urology #RARC #Neobladder #Pub2Post tinyurl.com/4kethxyf Maria Chiara Sighinolfi